You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Saudi Arabia

Nov 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Saudi Arabia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Saudi Arabia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Saudi Arabia for free:

The Consumer Health in Saudi Arabia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Saudi Arabia?
  • What are the major brands in Saudi Arabia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Increasingly proactive approach to consumer health drives growth

Consumer health saw strong growth during the review period, with expansion partly underpinned by high population growth. In addition, consumers adopted an increasingly proactive approach to health. Consumers became more sophisticated in their understanding of symptoms, their causes and treatments and were thus increasingly willing to self-medicate with OTC. This trend was further encouraged by strong satellite TV advertising for many brands, such as GlaxoSmithKline’s Panadol. Effective advertising is able to reassure consumers of a brand’s safety and efficacy and thus encourages self-medication.

Focus shifts from illness to wellness

Growing health awareness was also linked to media coverage of the country’s high levels of obesity and overweight, along with lifestyle diseases such as diabetes. Consequently, many consumers sought to improve their health, rather than simply to relieve the symptoms of ailments. Consumers also sought to stave off future ailments, with a growing number for example taking calcium supplements in order to prevent osteoporosis. This trend boosted sales of products such as weight management and vitamins and dietary supplements.

Consolidation continues as consumers opt for leading brands

The top five players in consumer health all gained share in value terms in 2010 over the previous year, as consumers increasingly opted for the leading brands. This was partly due to strong advertising support for many of these brands, such as Reckitt Benckiser’s Dettol and Ciba-Geigy’s Voltaren. In addition, consolidation was due to consumers associating many of the leading players with high quality and value. Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) was a strong leader in 2010, being the only player with a double-digit share, and was followed by GlaxoSmithKline, Reckitt Benckiser and Boots. Domestic player Riyadh Pharma meanwhile rounded out the top five.

Distribution continues to broaden

Chemists/pharmacies continued to dominate sales of consumer health at the end of the review period. Many products may only be sold via chemists/pharmacies, while these outlets are also most consumers’ automatic first choice when buying consumer health. However, chemists/pharmacies lost share to other channels in 2010, with healthfood shops notably gaining share. This channel notably benefited from the growing popularity of herbal/traditional products and also from a strong performance in weight management and allergy care.

Stronger growth ahead for forecast period

The forecast period is expected to see even stronger constant value growth for consumer health in comparison to that seen during the review period. Growth will continue to be underpinned by Saudi Arabia’s population and economic growth. In addition, players are expected to invest heavily in marketing and new product development during the forecast period, with many keen to capitalise on strong projected sales growth.

Table of Contents

Table of Contents

Consumer Health in Saudi Arabia - Industry Overview

EXECUTIVE SUMMARY

Increasingly proactive approach to consumer health drives growth

Focus shifts from illness to wellness

Consolidation continues as consumers opt for leading brands

Distribution continues to broaden

Stronger growth ahead for forecast period

KEY TRENDS AND DEVELOPMENTS

Economic growth supports stronger sales

Rapidly increasing population fuels growth

Weight problems gain attention

Expansion in health and beauty retailers boosts sales

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Saudi Arabia - Company Profiles

Jamjoom Pharma in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Jamjoom Pharma: Competitive Position 2010

Riyadh Pharma in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Riyadh Pharma: Competitive Position 2010

Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 11 Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Competitive Position 2010

Tabuk Pharmaceutical Manufacturing Co in Consumer Health (Saudi Arabia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Tabuk Pharmaceutical Manufacturing Co: Competitive Position 2010

Adult Mouth Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Consumers continued to become more aware of adult mouth care towards the end of the review period, with this trend boosting sales. This was largely thinks to new product development earlier in the review period, with Tabuk introducing affordable domestic brand Piodin in 2008. 2009 meanwhile saw the introduction of Optima’s herbal/traditional Aloedent brand, with this being the first herbal/traditional product to emerge in adult mouth care. This year also saw the launch of Zinopharma’s Zino Den-Sept. The introduction of these new products boosted consumer awareness, particularly as advertising and non-specialist distribution is permitted for adult mouth care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) was the clear leader in adult mouth care at the end of the review period, accounting for 35% value share. The company offers the widest range within adult mouth care, including Orasept Mouth Wash, Betadine Mouth Wash, Chlorasept and Florasept. The company however lost share towards the end of the review period, dropping from 36% share in 2009 and 37% share in 2005. This was due to growing competition as a result of strong new product development.

PROSPECTS

  • Adult mouth care is expected to benefit from a growing focus on oral care during the forecast period. Many Saudi consumers have a fondness for sweet flavours, which can lead to mouth and gum problems. During the forecast period, consumers are expected to become more aware of adult mouth care, particularly thanks to stronger advertising support and new product development towards the end of the review period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Acetaminophen remained the most popular product type in analgesics in 2010, accounting for 37% of overall value sales. Acetaminophen was also the main driving force for overall growth in analgesics in 2010. Acetaminophen benefits from affordable product pricing, a wide product variety and widespread distribution among both chemists/pharmacies and grocery retailers. This product area also benefits from the strong and longstanding presence of multinational brands such as GlaxoSmithKline’s Panadol and local brands such as Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO)’s Fevadol.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) faced aggressive competition from second-ranked player GlaxoSmithKline in 2010. Despite this, SPIMACO maintained its leadership and gained share in analgesics in 2010, rising by almost half a percentage point from 2009 to account for 28% value share. The company lost share to GlaxoSmithKline in acetaminophen in the second half of the review period, with the multinational investing more in advertising and new product launches. However, SPIMACO gained share elsewhere in analgesics due to its competitive product pricing and strong advertising support, particularly via medical media. The company’s best performing brands in 2010 remained Sapofen in ibuprofen, Rofenac in Diclofenac and Rofenac Gel in topical analgesics/anaesthetic.

PROSPECTS

  • Analgesics is expected to benefit from ongoing new product launches during the forecast period, with these focusing on offering added-value features. Leading players SPIMACO and GlaxoSmithKline will be at the forefront of new product development, although smaller players may also introduce new value-added variants. A key recent launch that is projected to perform well over the forecast period is Panadol Joint, which is expected to benefit from a high incidence of joint pain in the country and strong trust in the Panadol brand.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • The Saudi government struggled to control sales of Rx medicines at the end of the review period, with many of these products being freely sold UTC. However, while there was little attempt to control these sales as a whole, the government sought to prevent Rx sales of calming and sleeping products, due to the potential for addiction or misuse for these products. Consequently, Rx products became increasingly difficult to obtain, with many consumers thus switching to OTC products instead.

SWITCHES

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim continued to be the leading player in calming and sleeping products at the end of the review period. The company introduced its Songha Night brand in 2007, with this brand becoming the leader in its first year. Songha Night is higher priced than many of its competitors but has a strong reputation for quality and efficacy and thus enjoys widespread consumer loyalty. The brand also benefits from wide distribution.

PROSPECTS

  • Calming and sleeping products is expected to see a strong performance during the forecast period, with a constant value CAGR of 12%. Growth will be supported by increasingly stressful and busy consumer lifestyles and also by ongoing controls on Rx sales. In addition, consumers are expected to become more aware of the dangers and side effects associated with Rx calming and sleeping products during the forecast period, with a growing number thus opting for herbal/traditional OTC products.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Current value sales of cough, cold and allergy (hay fever) remedies continued to peak in 2010. Growth continued to be supported by the sandstorms that continued to hit many cities of the Kingdom during the autumn and summer seasons. Largely indoor lifestyles, the widespread use of air conditioning and the harsh climate of the country also contributed to high and growing demand for many products towards the end of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO) remained the clear leader in cough, cold and allergy (hay fever) remedies in 2010 with 18% value share. Despite a continued increase in competition from multinationals such as GlaxoSmithKline and Boots, the company further increased its lead in 2010 with a rise of almost half a percentage point in value share from 2009.

PROSPECTS

  • Between 2010-2015, cough, cold and allergy (hay fever) remedies is expected see its constant value CAGR increase to an impressive rate of 6%, up from 3% CAGR during the review period. In addition to long-term growth factors such as the country’s hot climate and desert environment, growth is projected to benefit from increased player investment, particularly from multinational companies such as GlaxoSmithKline and Wyeth-Ayerst International.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies maintained its review period momentum in 2010 thanks to strong player investment across almost all product categories, particularly antacids, child-specific digestive remedies, IBS treatments, proton pump inhibitors and antiflatulents. There was continued growth in TV advertising, with strong campaigns used to support brands such as GlaxoSmithKline’s Gaviscon in antacids. There was also strong new product development in many product categories, especially child-specific product areas, which saw launches such as Forest Laboratories’ Infacol and Deef’s Defopan in child-specific indigestion and heartburn remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Julphar Gulf Pharmaceuticals was able to retain its leading position in digestive remedies in 2010, ending the year with 15% value share. However, this represented a decline of around a percentage point from 2009 and four percentage points from 2006. The company lost share in antacids due to growing competition from GlaxoSmithKline’s well-advertised Gaviscon brand. Similarly, GlaxoSmithKline’s Zantac in H2 blockers also enjoys strong advertising support, with Julphar’s Rantag suffering in this product area also.

PROSPECTS

  • Sales of digestive remedies are predicted to grow at 1% constant value CAGR during the forecast period, with this representing an improvement in comparison to the 2% decline seen for the review period as a whole. Manufacturers will contribute to an improved performance with strong new product development. New launches are likely to follow trends in Europe and the US in terms of marketing claims/selling points, formulas, packaging and design, with a growing emphasis on the OTC status of products.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Ear care suffered from a lack of competition towards the end of the review period, with Riyadh Pharma being the only significant player. There was thus little incentive for Riyadh to push for share growth, with the company thus investing little in marketing or new product development. Consequently, ear care remained a tiny niche with sales reaching just SR2 million in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic player Riyadh Pharma is the only significant player in ear care and accounted for a dominant 94% value share in 2010. The company offers the Ear Calm brand, which is the only brand with a consistent and wide distribution presence. This brand is popular as it contains an analgesic component and thus relieves ear pain linked to infection or injury.

PROSPECTS

  • A lack of competition is expected to continue to constrain sales growth for ear care during the forecast period. Low sales in this product area and a general lack of consumer interest will continue to deter new entrants. Consumers are meanwhile likely to continue to opt for home-made remedies for minor ear problems and doctor’s visits and Rx medicines for more serious ear problems.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Sales of eye care continued to benefit from the widening use of contact lenses in Saudi Arabia during the review period and by the growing use of laser eye surgery. With a growing focus on appearance, consumers increasingly shied away from wearing glasses, with many opting for contact lenses and others opting for surgery. This resulted in growing use for eye care.

SWITCHES

COMPETITIVE LANDSCAPE

  • There were three strong leaders in eye care in 2010. Allergan accounted for 32% value share thanks to its Refresh range in standard eye care. Alcon meanwhile ranked second with 25% share due to its Naphcon brand in allergy eye care and Tears Naturale brand in standard eye care. Ciba Vision meanwhile ranked third with 19% value share, stemming mainly from the Viscotears brand in standard eye care. These players benefit from a longstanding presence in eye care and thus from established consumer loyalty. They also have the widest distribution within eye care.

PROSPECTS

  • The factors that supported strong growth for eye care during the review period are likely to continue to drive growth during the forecast period. There is expected to be an ongoing shift away from glasses and towards contact lenses and laser eye surgery, as consumers increasingly seek convenience and also focus on their appearance. Consumers are also likely to increasingly suffer from dry eye conditions as a result of spending more time staring at a screen due to ongoing growth in internet usage. These trends are mainly likely to benefit standard eye care, which is expected to see 6% constant value CAGR during the forecast period as a result.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2005-2010
  • Table 53 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 54 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 55 Eye Care Company Shares by Value 2006-2010
  • Table 56 Eye Care Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • There was growing consumer interest in herbal/traditional products during the review period, with many consumers being attracted by these products’ safe, natural and gentle image. Awareness of herbal/traditional products increased as a result of strong new product development during the review period and widening distribution. In addition, consumers became more sophisticated in their approach to consumer health, with increasing scrutiny of the side effects associated with standard products.

COMPETITIVE LANDSCAPE

  • Cadbury Adams and Nattermann International led sales of herbal/traditional products in 2010, accounting for 12% and 11% value share respectively. These players are both present in herbal/traditional cough, cold and allergy (hay fever) remedies, which is the dominant product area and accounted for 59% of overall value in herbal/traditional products in 2010. Cadbury Adams owes its position to the strength of its Halls brand in medicated confectionery, while Nattermann offers Bronchicum and Melrosum in child-specific cough remedies. These players have the strongest distribution within herbal/traditional products and offer well-established brands with a high quality reputation.

PROSPECTS

  • Herbal/traditional products are expected to move more into the mainstream during the forecast period, with consumers being increasingly attracted by these products’ gentle effect and natural ingredients. Growth in herbal/traditional products is likely to be supported by widening distribution and a growing recognition of these products’ benefits among doctors and pharmacists. This will result in more frequent recommendations for herbal/traditional products. In addition, herbal/traditional products will benefit from Saudi Arabia’s young consumer base, with these products regarded as particularly suitable for children.

CATEGORY DATA

  • Table 59 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 60 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 61 Herbal/Traditional Products Company Shares 2006-2010
  • Table 62 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 63 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 64 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Continuing the trends seen in 2009, medicated shampoos and hair loss treatments were the only product categories to see current value sales decline in 2010. Medicated shampoos lost share to cosmetic anti-dandruff shampoo, sales of which grew strongly during 2010. This was thanks to the outstanding performance of multinational brands such as Unilever’s Clear and Sunsilk, Procter & Gamble’s Dove and Procter & Gamble’s Head & Shoulders. Sales of hair loss treatments were also negatively affected by cosmetic skin care, with innovative variants claiming to prevent hair loss such as Clear Hair Fall Defence and Head & Shoulders Hair Fall Defence.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated skin care is highly fragmented, with only Reckitt Benckiser holding a double-digit value share in 2010. The top 10 features mainly multinational companies, also including Janssen-Cilag, Schering-Plough, Leo Pharmaceutical, Johnson & Johnson and Pfizer. All of these players have been present in medicated skin care for decades and many of their best-selling brands enjoy strong loyalty among both consumers and healthcare professionals.

PROSPECTS

  • Medicated skin care is expected to grow at a healthier rate during the forecast period, with a constant value CAGR of 4% in comparison to the review period CAGR of 2%. Strong growth is projected to continue in many leading product categories, including topical germicidals/antiseptics, antipruritics, haemorrhoid treatments, acne treatments and nappy (diaper) rash treatments. Growth will be underpinned by widening awareness, strengthening distribution, strong advertising support, a growing focus on hygiene and by demographic factors. Acne treatments and nappy (diaper) rash treatments will for example benefit from the country’s young population.

CATEGORY DATA

  • Table 65 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 66 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 67 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 70 Acne Treatments Brand Shares by Value 2007-2010
  • Table 71 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Several measures were introduced by the Saudi government to reduce the incidence of smoking during the review period. These included a ban on smoking in all public areas and aggressive taxation on tobacco products. Despite this, and the conservative nature of the Saudi community, smoking prevalence remained very high at 30% of the total population in 2010. Males comprised more than three-quarters of smokers, with a smoking prevalence of 42%, while the female smoking population remained small with a prevalence of 15%. Most consumers frown upon the idea of women smoking.

SWITCHES

COMPETITIVE LANDSCAPE

  • NRT smoking cessation aids is highly concentrated and is characterised by the monopoly of Novartis. The immature nature of this product area, low value sales and restricted distribution to chemists/pharmacies discouraged many manufacturers from entering. With the exit of Pfizer’s Nicorette in 2007 and the absence of any other competitor, Novartis accounted for all sales in 2010.

PROSPECTS

  • During the review period, constant value sales for NRT smoking cessation aids declined by 48%. This decline is expected to continue during the forecast period, although at a lower rate of 19%. Decline will continue to be linked to strong competition from well-performing Rx brand Champix and the possible entry of new RX brands such as GlaxoSmithKline’s Zyban.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Sales of sports nutrition benefited in 2010 from a growing focus on appearance. Consequently, a growing number of Saudi men began to lift weight and sought to build their muscles in order to create a well-toned appearance. This trend supported 9% current value growth in 2010 over the previous year, with growth only slowing slightly in comparison to a review period CAGR of 10% due to a higher sales base.

COMPETITIVE LANDSCAPE

  • MuscleTech Research & Development was the clear leader in sports nutrition in 2010 with a value share of 28%. The company benefits from having a longstanding presence via the Armal healthfood shops chain and other channels, and enjoys a strong reputation. The company’s most significant products are Cell-Tech and MuscleTech Creatine 600ES.

PROSPECTS

  • Sales growth will continue to be hindered by a number of factors in sports nutrition. Firstly, these products suffer from a limited consumer base, with most Saudis being more interested in losing weight than in building muscle. Sales are thus limited largely to young male bodybuilders and professional athletes. The high price of sports nutrition will also continue to hinder sales growth, as will limited distribution. Consequently, sports nutrition is expected to see less than 4% constant value CAGR during the forecast period, with growth down slightly in comparison to that seen during the review period.

CATEGORY DATA

  • Summary 15 Sports Nutrition, category rankings 2010
  • Table 82 Sales of Sports Nutrition: Value 2005-2010
  • Table 83 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 84 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 85 Sports Nutrition Company Shares 2006-2010
  • Table 86 Sports Nutrition Brand Shares 2007-2010
  • Table 87 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 88 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Consumers showed an increasingly proactive approach to health towards the end of the review period, which greatly benefited sales of vitamins and dietary supplements. There was a growing focus on preventative medicine, with many for example taking calcium supplements in order to ward off potential osteoporosis. In addition, a growing number of consumers began to take multivitamins on a daily basis in order to improve their general health and wellbeing.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • General Nutrition Centers led fragmented sales of vitamins and dietary supplements at the end of the review period, accounting for 12% value share in 2010. The company’s leadership is due to its extremely wide range, which encompasses multivitamins, single vitamins and a wide range of dietary supplements. The company is the only player to enjoy widespread distribution in many niches, which it thus dominates. The company thus accounted for over 90% value share in a number of products in 2010, including ashwagandha, sam-E, alpha lipoic acid, DHEA, lecithin and melatonin.

PROSPECTS

  • Consumers are expected to become increasingly well-informed and sophisticated in their understanding of vitamins and dietary supplements during the forecast period. There is expected to be an increasingly proactive approach to health and wellness, with consumers exploring the latest health trends via the internet, TV and magazines and newspapers. Consequently, a growing number of consumers are expected to take vitamins and dietary supplements on a daily basis as they seek to boost their energy and health.

CATEGORY DATA

  • Summary 16 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 91 Dietary Supplements by Positioning 2005-2010
  • Table 92 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 93 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 94 Vitamins Brand Shares by Value 2007-2010
  • Table 95 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Saudi Arabia suffers from widespread weight problems, with around a third of the population being obese at the end of the review period and around 70% being overweight. Widespread weight problems in turn result in a high incidence of ailments such as diabetes, high blood pressure and heart problems. There was growing media coverage of the dangers of excess weight towards the end of the review period, with this being encouraged by the Ministry of Health’s consumer awareness campaign Balance Your Life. Consequently, consumers became more aware of the connections between weight and health, with many seeking to lose weight as a result.

COMPETITIVE LANDSCAPE

  • Twinlab was the clear leader in weight management in 2010 and also saw the strongest gain in value share over the previous year. The company rose by almost two percentage points to account for 19% share. This was entirely due to the company’s strength in meal replacement slimming, where the company accounted for 47% value share in 2010 and gained two percentage points over the previous year. The company benefited from further expanding distribution reach for its Fibresol brand and also from offering affordable prices.

PROSPECTS

  • Saudi Arabia is expected to continue to suffer from widespread weight problems during the forecast period. Many consumers are aware that they need to exercise and to eat more healthily. However, most Saudis drive everywhere, lead sedentary lifestyles and are increasingly reliant on fast food and processed food. Cultural expectations also hinder Saudi women from exercising outside. Consequently, the number of overweight or obese consumers is expected to rise further during the forecast period.

CATEGORY DATA

  • Table 98 Sales of Weight Management: Value 2005-2010
  • Table 99 Sales of Weight Management: % Value Growth 2005-2010
  • Table 100 Weight Management Company Shares 2006-2010
  • Table 101 Weight Management Brand Shares 2007-2010
  • Table 102 Forecast Sales of Weight Management: Value 2010-2015
  • Table 103 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Saudi Arabia - Category Analysis

HEADLINES

TRENDS

  • Strong growth in wound care continued to be supported by Johnson & Johnson’s advertising investment towards the end of the review period. In 2009 and 2010, the company notably invested in frequent TV advertising for Band-Aid Aloe Vera and Band-Aid Liquid Bandage, with these being value-added variants of its Band-Aid range. The company also used frequent in-store promotions to attract consumer interest, thus driving strong growth in wound care.

COMPETITIVE LANDSCAPE

  • Two multinationals with strong and well-established brands led sales of wound care throughout the review period. In 2010, Johnson & Johnson was the clear leader, with its Band-Aid brand accounting for 40% share. 3M meanwhile ranked second, with its 3M and Nexcare brands together accounting for 31% value share.

PROSPECTS

  • Liquid bandages are expected to continue to grow in popularity during the forecast period. Increasingly, households are likely to keep sticking plasters/adhesive bandages, gauze and liquid bandages in stock in order to cater for a wide range of wounds. Strong growth during the review period was underpinned by advertising for Band-Aid Liquid Bandage, with this likely to remain the leading brand in the area during the forecast period.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2005-2010
  • Table 105 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 106 Wound Care Company Shares by Value 2006-2010
  • Table 107 Wound Care Brand Shares by Value 2007-2010
  • Table 108 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Ashwagandha
            • Dandelion
            • Dong Quai
            • Fenugreek
            • Hops
            • Horsetail
            • Isoflavones
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Alpha Lipoic Acid
            • Chitosan
            • DHEA
            • Lecithin
            • Melatonin
            • Yeast
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?